Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GIBALDI M")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 106

  • Page / 5
Export

Selection :

  • and

Regulating angiogenesis : A new therapeutic strategyGIBALDI, M.Journal of clinical pharmacology. 1998, Vol 38, Num 10, pp 898-903, issn 0091-2700Article

The eleventh International conference on AIDS : Cautious celebration in VancouverGIBALDI, M.Journal of clinical pharmacology. 1997, Vol 37, Num 1, pp 20-24, issn 0091-2700Article

Antioxidant vitamins and healthGIBALDI, M.Journal of clinical pharmacology. 1996, Vol 36, Num 12, pp 1093-1099, issn 0091-2700Article

Anatomy of an antibody, and related misadventures in developing an effective treatment for septic shockGIBALDI, M.Pharmacotherapy. 1993, Vol 13, Num 4, pp 302-308, issn 0277-0008Article

PHARMACOKINETICS IN CLINICAL PRACTICE. I. CONCEPTSGIBALDI M; LEVY G.1976; J.A.M.A.; U.S.A.; DA. 1976; VOL. 235; NO 17; PP. 1864-1867Article

DRUG CONCENTRATIONS IN THE PLASMA AS AN INDEX OF PHARMACOLOGIC EFFECT = LES CONCENTRATIONS DES MEDICAMENTS DANS LE PLASMA EN TANT QU'INDICE DE L'EFFET PHARMACOLOGIQUEPERRIER D; GIBALDI M.1974; J. CLIN. PHARMACOL.; U.S.A.; DA. 1974; VOL. 14; NO 8-9; PP. 415-417; BIBL. 7REF.Article

ENHANCEMENT OF INTESTINAL ABSORPTION OF A QUATERNARY AMMONIUM COMPOUND BY SALICYLATE AND TRICHLOROACETATE = ACCROISSEMENT DE L'ABSORPTION INTESTINALE D'UN COMPOSE AMMONIUM QUATERNAIRE PAR LES SALICYLATES ET LES TRICHLOROACETATESGIBALDI M; GRUNDHOFER B.1972; J. PHARM. SCI.; U.S.A.; DA. 1972; VOL. 62; NO 2; PP. 343-344; BIBL. 8 REF.Serial Issue

COMPARISON OF OBSERVED AND PREDICTED BIOAVAILABILITY OF NORTRIPTYLINE IN HUMANS FOLLOWING ORAL ADMINISTRATION = COMPARAISON DE LA BIODISPONIBILITE OBSERVEE ET PREVUE DE LA NORTRIPTYLINE CHEZ L'HOMME A LA SUITE DE L'ADMINISTRATION PER OSGIBALDI M.1975; J. PHARM. SCI.; U.S.A.; DA. 1975; VOL. 64; NO 6; PP. 1036-1037; BIBL. 6REF.Article

Failure to comply : A therapeutic dilemma and the bane of clinical trialsGIBALDI, M.Journal of clinical pharmacology. 1996, Vol 36, Num 8, pp 674-682, issn 0091-2700Article

INFLUENCE OF FIRST-PASS EFFECT ON THE SYSTEMIC AVAILABILITY OF PROPOXYPHENE = INFLUENCE DE L'EFFET D'UN PREMIER PASSAGE SUR LA DISPONIBILITE GENERALE DU PROPOXYPHENEPERRIER D; GIBALDI M.1972; J. CLIN. PHARMACOL.; U.S.A.; DA. 1972; VOL. 12; NO 11-12; PP. 449-452; BIBL. 13 REF.Serial Issue

What is nitric oxide and why are so many people studying it ?GIBALDI, M.Journal of clinical pharmacology. 1993, Vol 33, Num 6, pp 488-496, issn 0091-2700Article

Stereoselective and isozyme-selective drug interactionsGIBALDI, M.Chirality (New-York, NY). 1993, Vol 5, Num 6, pp 407-413, issn 0899-0042Article

Meta-analysis : a review of its place in therapeutic decision makingGIBALDI, M.Drugs (Basel). 1993, Vol 46, Num 5, pp 805-818, issn 0012-6667Article

CLEARANCE AND BIOLOGIC HALF-LIFE AS INDICES OF INTRINSIC HEPATIC METABOLISM = LA CLEARANCE ET LA DEMI-VIE BIOLOGIQUE EN TANT QU'INDICES DU METABOLISME HEPATIQUE INTRINSEQUEPERRIER D; GIBALDI M.1974; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1974; VOL. 191; NO 1; PP. 17-24; BIBL. 14 REF.Article

Prevention and treatment of osteoporosis: Does the future belong to hormone replacement therapy?GIBALDI, M.Journal of clinical pharmacology. 1997, Vol 37, Num 12, pp 1087-1099, issn 0091-2700Article

SINGLE POINT ESTIMATION OF PHENYTOIN DOSING REQUIREMENTKOUP JR; GIBALDI M.1981; RES. COMMUN. CHEM. PATHOL. PHARMACOL.; ISSN 0034-5164; USA; DA. 1981; VOL. 31; NO 1; PP. 3-12; BIBL. 12 REF.Article

PLASMA PROTEIN BINDING OF DIAZEPAM AFTER A SINGLE DOSE OF SODIUM OLEATE.COLBURN WA; GIBALDI M.1978; J. PHARM. SCI.; USA; DA. 1978; VOL. 67; NO 6; PP. 891-892; BIBL. 2 REF.Article

USE OF MULTDOS FOR PHARMACOKINETIC ANALYSIS OF ETHOSUXIMIDE DATA DURING REPETITIVE ADMINISTRATION OF SINGLE OR DIVIDED DAILY DOSES.COLBURN WA; GIBALDI M.1978; J. PHARM. SCI.; U.S.A.; DA. 1978; VOL. 67; NO 4; PP. 574-575; BIBL. 5 REF.Article

APPARENT VOLUMES OF DISTRIBUTION AND DRUG BINDING TO PLASMA PROTEINS AND TISSUES.GIBALDI M; MCNAMARA PJ.1978; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1978; VOL. 13; NO 5; PP. 373-378; BIBL. 11 REF.Article

PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL FOR DIGOXIN DISPOSITION IN DOGS AND ITS PRELIMINARY APPLICATION TO HUMANS.HARRISON LI; GIBALDI M.1977; J. PHARM. SCI.; U.S.A.; DA. 1977; VOL. 66; NO 12; PP. 1679-1683; BIBL. 48 REF.Article

PHARMACOKINETICS IN CLINICAL PRACTICE. II. APPLICATIONS.GIBALDI M; LEVY G.1976; J.A.M.A.; U.S.A.; DA. 1976; VOL. 235; NO 18; PP. 1987-1992; BIBL. 14 REF.Article

BIOAVAILABILITY OF ASPIRIN FROM COMMERCIAL SUPPOSITORIESGIBALDI M; GRUNDHOFER B.1975; J. PHARM. SCI.; U.S.A.; DA. 1975; VOL. 64; NO 6; PP. 1064-1066; BIBL. 2REF.Article

Helicobacter pylori and gastrointestinal diseaseGIBALDI, M.Journal of clinical pharmacology. 1995, Vol 35, Num 7, pp 647-654, issn 0091-2700Article

PHARMACOKINETIC CONCEPTS: DRUG BINDING, APPARENT VOLUME OF DISTRIBUTION AND CLEARANCEGIBALDI M; KOUP JR.1981; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1981; VOL. 20; NO 4; PP. 299-305; BIBL. 17 REF.Article

SOME COMMENTS ON THE EVALUATION OF BISAVAILABILITY DATAKOUP JR; GIBALDI M.1980; DRUG INTELLIG. CLIN. PHARM.; USA; DA. 1980; VOL. 14; NO 5; PP. 327-330; ABS. FRE; BIBL. 6 REF.Article

  • Page / 5